Article: FDA panel backs rotavirus vaccine.(Infectious Diseases)

BETHESDA, MD. -- A Food and Drug Administration advisory committee has given unanimous backing to a rotavirus vaccine, Merck and Co.'s RotaTeq.

In two 10-0 votes, the Vaccines and Related Biological Products Advisory Committee said that RotaTeq is both effective and safe. If the agency follows the advice of its panel, which it generally does, the vaccine could be approved by February 2006, the legal deadline for FDA action on RotaTeq.

Panelists were mostly concerned with the vaccine's safety, particularly whether it was linked to intussusception, a potentially fatal condition in which the bowel telescopes in on itself. The only previously approved ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!